• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.

作者信息

Rüggeberg Jens U, Gold Michael S, Bayas José-Maria, Blum Michael D, Bonhoeffer Jan, Friedlander Sheila, de Souza Brito Glacus, Heininger Ulrich, Imoukhuede Babatunde, Khamesipour Ali, Erlewyn-Lajeunesse Michel, Martin Susana, Mäkelä Mika, Nell Patricia, Pool Vitali, Simpson Nick

机构信息

Pädiatrische Infektiologie, Universitätskinderklinik Düsseldorf, Germany.

出版信息

Vaccine. 2007 Aug 1;25(31):5675-84. doi: 10.1016/j.vaccine.2007.02.064. Epub 2007 Mar 12.

DOI:10.1016/j.vaccine.2007.02.064
PMID:17448577
Abstract
摘要

相似文献

1
Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.过敏反应：免疫接种安全性数据的病例定义及数据收集、分析与呈现指南
Vaccine. 2007 Aug 1;25(31):5675-84. doi: 10.1016/j.vaccine.2007.02.064. Epub 2007 Mar 12.
2
Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data.血小板减少症：免疫接种安全性数据的病例定义及收集、分析和呈现指南。
Vaccine. 2007 Aug 1;25(31):5717-24. doi: 10.1016/j.vaccine.2007.02.067. Epub 2007 Mar 12.
3
Rash including mucosal involvement: case definition and guidelines for collection, analysis, and presentation of immunization safety data.包括黏膜受累的皮疹：免疫接种安全性数据的病例定义及收集、分析和报告指南
Vaccine. 2007 Aug 1;25(31):5697-706. doi: 10.1016/j.vaccine.2007.02.066. Epub 2007 Mar 13.
4
Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data.注射部位或其附近肿胀：免疫接种安全性数据收集、分析及呈现的病例定义与指南
Vaccine. 2007 Aug 1;25(31):5858-74. doi: 10.1016/j.vaccine.2007.04.056. Epub 2007 May 11.
5
Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.注射部位或其附近的硬结：免疫接种安全性数据的收集、分析及呈现的病例定义与指南
Vaccine. 2007 Aug 1;25(31):5839-57. doi: 10.1016/j.vaccine.2007.04.062. Epub 2007 May 8.
6
Fatigue: case definition and guidelines for collection, analysis, and presentation of immunization safety data.疲劳：免疫接种安全性数据收集、分析及呈现的病例定义与指南
Vaccine. 2007 Aug 1;25(31):5685-96. doi: 10.1016/j.vaccine.2007.02.065. Epub 2007 Mar 12.
7
Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data.无菌性脑膜炎：免疫接种安全性数据的病例定义及收集、分析和呈现指南。
Vaccine. 2007 Aug 1;25(31):5793-802. doi: 10.1016/j.vaccine.2007.04.058. Epub 2007 May 8.
8
Inadvertent inoculation as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.接种牛痘病毒暴露后的不良事件——意外接种：免疫安全数据的数据收集、分析和呈现的病例定义及指南
Vaccine. 2007 Aug 1;25(31):5754-62. doi: 10.1016/j.vaccine.2007.02.087. Epub 2007 May 4.
9
Robust take following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data.接种牛痘病毒后的强烈反应：免疫安全性数据的病例定义及数据收集、分析和呈现指南
Vaccine. 2007 Aug 1;25(31):5763-70. doi: 10.1016/j.vaccine.2007.04.063. Epub 2007 May 11.
10
Eczema vaccinatum as an adverse event following exposure to vaccinia virus: case definition & guidelines of data collection, analysis, and presentation of immunization safety data.接种牛痘病毒后发生的湿疹痘：暴露后不良事件的病例定义及免疫安全性数据收集、分析和报告指南。
Vaccine. 2007 Aug 1;25(31):5725-34. doi: 10.1016/j.vaccine.2007.02.085. Epub 2007 May 2.

引用本文的文献

1
Establishing a Multicenter Active Adverse Events Following Immunization Sentinel Surveillance Network Across 22 Tertiary Care Hospitals in India: Protocol for a Prospective Observational Study.在印度22家三级护理医院建立免疫接种后多中心主动不良事件哨点监测网络：一项前瞻性观察性研究方案
JMIR Res Protoc. 2025 Aug 8;14:e64050. doi: 10.2196/64050.
2
The safety of co-administration of recombinant zoster vaccine (Shingrix) and influenza vaccines in the elderly in VAERS during 2018-2024.2018 - 2024年期间，美国疫苗不良事件报告系统（VAERS）中重组带状疱疹疫苗（Shingrix）与流感疫苗联合接种在老年人中的安全性。
Hum Vaccin Immunother. 2025 Dec;21(1):2525603. doi: 10.1080/21645515.2025.2525603. Epub 2025 Jul 11.
3
Resolution of Patient's Anaphylaxis to the Moderna COVID-19 Vaccine by Desensitization.
通过脱敏疗法解决患者对Moderna新冠疫苗的过敏反应
HCA Healthc J Med. 2025 Apr 1;6(2):167-170. doi: 10.36518/2689-0216.1792. eCollection 2025.
4
JYNNEOS vaccine safety surveillance in the vaccine safety datalink during the 2022 mpox outbreak in the United States.2022年美国猴痘疫情期间疫苗安全数据链中JYNNEOS疫苗的安全性监测
Infection. 2024 Nov 20. doi: 10.1007/s15010-024-02428-1.
5
Delivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the Congo.在刚果民主共和国疫情期间，两剂预防性埃博拉病毒病疫苗在孕妇和非孕妇参与者中的接种与安全性
Vaccines (Basel). 2024 Jul 23;12(8):825. doi: 10.3390/vaccines12080825.
6
Development of Interoperable Computable Phenotype Algorithms for Adverse Events of Special Interest to Be Used for Biologics Safety Surveillance: Validation Study.用于生物制品安全性监测的特殊关注不良事件的可互操作可计算表型算法的开发：验证研究。
JMIR Public Health Surveill. 2024 Jul 15;10:e49811. doi: 10.2196/49811.
7
Incidence and management of the main serious adverse events reported after COVID-19 vaccination.报告的 COVID-19 疫苗接种后主要严重不良事件的发生率和处理。
Pharmacol Res Perspect. 2024 Jun;12(3):e1224. doi: 10.1002/prp2.1224.
8
Breathless encounters: Analyzing anaphylaxis at the crossroads of COVID-19 vaccination.气喘吁吁的遭遇：在新冠疫苗接种的十字路口分析过敏反应
Qatar Med J. 2024 Mar 24;2024(2):9. doi: 10.5339/qmj.2024.qitc.9. eCollection 2024.
9
Canadian vaccine safety surveillance reports following immunization with seasonal influenza vaccines, 2021-2022.2021 - 2022年加拿大季节性流感疫苗免疫接种后的疫苗安全性监测报告
Can Commun Dis Rep. 2024 Jan 1;50(1-2):16-24. doi: 10.14745/ccdr.v50i12a02.
10
A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination.一项评估 COVID-19 mRNA 疫苗接种后全身性过敏反应复发的随机双盲试验。
J Allergy Clin Immunol. 2024 Jun;153(6):1634-1646. doi: 10.1016/j.jaci.2024.03.001. Epub 2024 Mar 7.